CANSORTIUM INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.18 USD | 0.00% |
|
+5.88% | +100.00% |
| May. 16 | Cansortium Inc. Announces Chief Financial Officer Changes | CI |
| Apr. 30 | Cansortium Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 106M | Sales 2025 * | 119M | Capitalization | 53.92M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.51 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.45 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.94% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cansortium Inc.
More press releases
| 1 week | +5.88% | ||
| Current month | -14.29% | ||
| 3 months | +9.09% | ||
| 6 months | +63.64% | ||
| Current year | +100.00% |
1 week
0.17
0.19
1 month
0.150.22
Current year
0.090.28
1 year
0.060.28
3 years
0.061.17
5 years
0.001.99
10 years
0.002.20
| Managers | Title | Age | Since |
|---|---|---|---|
Robert Beasley
CEO | Chief Executive Officer | - | 20-09-28 |
Henry Batievsky
FOU | Founder | - | 18-08-30 |
Sean Mansouri
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Roger Daher
BRD | Director/Board Member | 58 | 20-04-06 |
Henry Batievsky
FOU | Founder | - | 18-08-30 |
Robert Beasley
CEO | Chief Executive Officer | - | 20-09-28 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 0.18 | 0.00% | 67,201 |
| 24-05-16 | 0.18 | +5.88% | 112,012 |
| 24-05-15 | 0.17 | -2.86% | 57,200 |
| 24-05-14 | 0.175 | +2.94% | 21,080 |
Delayed Quote Canadian Securities Exchange, May 17, 2024 at 02:48 pm EDT
More quotes
Cansortium Inc. is a vertically integrated cannabis company with licenses and operations in Florida, Pennsylvania and Texas. The Company operates under the private label, Fluent. The Company, through its subsidiaries, is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The Companyâs medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges and edibles and accessories. The Companyâs subsidiaries include Cansortium Holdings LLC, Cansortium Pennsylvania, LLC, Cansortium Puerto Rico, LLC, Cansortium Texas, LLC, Cansortium Canada Holdings Inc., Fluent Servicing, LLC, Cansortium Florida, LLC., Spirit Lake Road Nursery, LLC, Harvest Park Lot 9 Investors LLC, Fluent Hemp LLC and Cansortium Michigan LLC.
Calendar
2024-05-28
- Q1 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.18
USD
Average target price
0.7
USD
Spread / Average Target
+288.89%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +100.00% | 53.92M | |
| -.--% | 339M | |
| +52.26% | 299M | |
| +35.05% | 279M | |
| +167.11% | 154M | |
| +45.65% | 132M | |
| -41.95% | 119M | |
| -28.57% | 122M | |
| +34.62% | 118M | |
| +100.00% | 60.26M |
- Stock Market
- Equities
- TIUM.U Stock